Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
2(29%)
Results Posted
100%(3 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_4
1
14%
Ph phase_2
2
29%
Ph phase_1
1
14%
Ph phase_3
1
14%
Ph not_applicable
2
29%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Recruiting2
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (14.3%)
Phase 22 (28.6%)
Phase 31 (14.3%)
Phase 41 (14.3%)
N/A2 (28.6%)

Trials by Status

recruiting229%
terminated114%
not_yet_recruiting114%
completed343%

Recent Activity

2 active trials
Showing 5 of 7
recruitingphase_2

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

NCT04333537
not_yet_recruitingnot_applicable

STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection

NCT07612293
recruitingnot_applicable

PET/CT Follow up for Head and Neck Squamous Cell Carcinoma

NCT05707078
completedphase_2

Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer

NCT02784288
completedphase_1

Neck Dissection Via a Robot-assisted Transaxillary Approach in Patients With Squamous Cell Carcinoma of the Epi-larynx

NCT02269020
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT04333537Phase 2

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Recruiting
NCT07612293Not Applicable

STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection

Not Yet Recruiting
NCT05707078Not Applicable

PET/CT Follow up for Head and Neck Squamous Cell Carcinoma

Recruiting
NCT02784288Phase 2

Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer

Completed
NCT02269020Phase 1

Neck Dissection Via a Robot-assisted Transaxillary Approach in Patients With Squamous Cell Carcinoma of the Epi-larynx

Completed
NCT00360971Phase 3

Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer

Terminated
NCT02597582Phase 4

LigaSure Small Jaw® Versus Conventional Neck Dissection in Head and Neck Cancer Patients

Completed

All 7 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
7